Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Healthcare of the Russian Federation
Abstract
The article reviews the key approaches to the use of modified response evaluation criteria in solid tumors (mRECIST) in patients with hepatocellular carcinoma and discusses its main strengths and features. According to the evaluation by mRECIST, complete response is defined as the disappearance of any intratumoral arterial enhancement in all target lesions. A partial response is defined as 30% decrease in the sum of the longest diameters of viable tumor target lesions compared with its baseline sum. Disease progression signifies a ≥20% increase in the sum of the longest diameters of viable tumor target lesions compared with nadir. Stable disease is defined as neither partial response nor progression.
Publisher
Annals of Surgical Hepatology
Subject
Gastroenterology,Hepatology,Surgery
Reference37 articles.
1. Zhou M., Wang H., Zeng X., Yin P., Zhu J., Chen W., Li X., Wang L., Wang L., Liu Y., Liu J., Zhang M., Qi J., Yu S., Afshin A., Gakidou E., Glenn S., Krish V.S., Miller-Petrie M.K., Mountjoy-Venning W.C., Mullany C.E., Redford S.B., Liu H., Naghavi M., Hay I.S., Wang L., Murray C.J.L., Liang X. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394 (10204): 1145–1158. https://doi.org/10.1016/S0140-6736(19)30427-1
2. Bray F., Ferlay J., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68 (6): 394–424. https://doi.org/10.3322/caac.21492
3. World Health Organization. Projections of mortality and causes of death, 2016 to 2060. Available from: https://www.who.int/ healthinfo/global_burden_disease/projections/en/ (accessed July 9, 2019). 4. International Agency for Research on Cancer. Global cancer observatory – cancer fact sheets. Available from: http://gco.iarc. fr/today/fact-sheets-cancers (accessed July 9, 2019).
4. European Association for the Study of the Liver. European Organisation for Research and Treatment of Cancer. EASLEORTC clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 2012; 56 (4): 908–943. https://doi.org/10.1016/j.jhep.2011.12.001
5. Morris-Stiff G., Gomez D., de Liguori Carino N., Prasad K.R. Surgical management of hepatocellular carcinoma: is the jury still out? Surg. Oncol. 2009; 18 (4): 298–321. https://doi.org/10.1016/j.suronc.2008.08.003